DalsnaFinance › Analyst accuracy › Oppenheimer › AMGN target
AMGN Maintains Outperform Rating by Oppenheimer -- Price Target Raised to $450
Amgen had its price target raised by Oppenheimer Holdings, Inc. from $400.00 to $450.00.
A fact about what Oppenheimer published, as reported by GuruFocus, not a recommendation from Dalsna Finance; Oppenheimer is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.